Why is Sun Pharma.Inds. falling/rising?

As of 05-Jun, Sun Pharmaceutical Industries Ltd is experiencing a price increase, currently at 1,683.25, reflecting a change of 18.0 or 1.08% upward. Today's performance indicates a trend reversal as the stock has gained after four consecutive days of decline. While the stock is currently above its 5-day moving averages, it remains below the longer-term moving averages of 20, 50, 100, and 200 days. Despite a recent fall in delivery volume by 41.14% against the 5-day average, the stock maintains a healthy liquidity level for trading. Over the past week, the stock has decreased by 0.98%, and over the last month, it has fallen by 8.27%, contrasting with a 13.16% increase over the past year.
In the broader market context, the Sensex has shown a slight decline of 0.23% over the past week and a modest gain of 0.80% over the past month, indicating that Sun Pharma's short-term performance is lagging behind the benchmark. Despite this, the company benefits from high management efficiency, a low debt-to-equity ratio, and strong institutional holdings, which contribute positively to its long-term growth prospects. However, the recent flat quarterly results and a bearish technical trend may be contributing to investor caution. The stock's premium valuation compared to peers, coupled with a high PEG ratio, suggests that while it has performed well historically, current valuations may be seen as expensive, impacting investor sentiment.